New regulations continue to dampen clinical trial activity in Russia
This article was originally published in SRA
Executive Summary
Clinical trial activity in Russia is still on the decline following the introduction of new regulations last year. The total number of trials approved in the first half of 2011 fell by 36% to just 200, with trials conducted locally by domestic sponsors most affected, falling by around 80%, according to the Russian clinical trials organisation, ACTO1.